DUBs and disease: activity assays for inhibitor development

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Deubiquitinating enzymes (DUBs) regulate protein stability by cleaving ubiquitin, influencing proteasomal degradation.
• DUB activity is linked to diseases such as cancer and neurodegeneration, affecting oncogenic proteins and tumor suppressors.
• Despite their importance, the selectivity and reactivity of DUBs within the ubiquitin-proteasome system remain poorly understood.

Purpose of the Study:

• To review established in vitro methods for studying deubiquitinating enzyme (DUB) action.
• To discuss the application of these methods in the discovery of DUB inhibitors.
• To highlight the current gaps in understanding DUB selectivity and reactivity.

Main Methods:

• Literature review of published in vitro assays for DUB activity.
• Analysis of methods used for screening and characterizing DUB inhibitors.
• Discussion of techniques applicable to studying DUB selectivity and kinetics.

Main Results:

• Various in vitro methods exist to analyze DUB enzymatic activity.
• These methods are crucial for identifying small molecules that modulate DUB function.
• The review consolidates knowledge on studying DUBs, aiding future research.

Conclusions:

• In vitro assays are essential tools for investigating deubiquitinating enzyme mechanisms.
• Understanding DUBs is critical for developing targeted therapies for diseases like cancer.
• Further research is needed to fully elucidate DUB selectivity and reactivity for improved therapeutic strategies.